Article
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas.
International journal of cancer - 1 Aug 2025
Chouleur Tiffanie, Etchegaray Christèle, Villain Laura, Lesur Antoine, Ferté Thomas, Rossi Marco, Andrique Laetitia, Simoncini Costanza, Giacobbi Anne-Sophie, Gambaretti Matteo, Lopci Egesta, Fernades Bethania, Dittmar Gunnar, Bjerkvig Rolf, Hejblum Boris, Thiébaut Rodolphe, Saut Olivier, Bello Lorenzo, Bikfalvi Andreas
Abstract excerpt
Isocitrate dehydrogenase-mutant gliomas are lethal brain cancers that impair quality of life in young adults. Although less aggressive than glioblastomas, IDH-mutant gliomas invariably progress to incurable disease with unpredictable recurrence. A better classification of patient risk of recurrence is needed. Here, we describe a multimodal analytical pipeline integrating imaging, transcriptomic, and proteomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
